Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine …
Objective We investigated prolonged COVID-19 symptom duration, defined as lasting 28
days or longer, among people with systemic autoimmune rheumatic diseases (SARDs) …
days or longer, among people with systemic autoimmune rheumatic diseases (SARDs) …
[HTML][HTML] The Recent Updates on Neoteric Variants of Covid-19 Virus and Therapeutic Effectiveness of Vaccines against the Variants
S Chaudhary, AN El-Shorbagi… - Biomedical and …, 2022 - biomedpharmajournal.org
Abstract The coronavirus 2 illness (Covid-19) global pandemic has resulted in severe
infection causing fever, cough, shortness of breath, pneumonia and even death. WHO is …
infection causing fever, cough, shortness of breath, pneumonia and even death. WHO is …
A retrospective study of the proportional distribution of ABO blood types in SARS-CoV-2 patients in Jodhpur (western India)
V Choudhary, PK Khatri, P Khinvasara, GK Aseri… - The Journal of Infection …, 2024 - jidc.org
Abstract Introduction: Coronavirus disease 2019 (COVID-19) has infected millions of people
globally. Many recent studies have suggested that the ABO blood type may contribute to …
globally. Many recent studies have suggested that the ABO blood type may contribute to …
[PDF][PDF] Clinical profile and epidemiological characteristics of COVID-19 patients admitted in the district hospital of North India-a retrospective study
Background: During COVID-19 all the tertiary institutes were overburdened so all the
peripheral institutes, mostly district hospitals were made functional to provide management …
peripheral institutes, mostly district hospitals were made functional to provide management …
[PDF][PDF] Correlations Between Covid 19 Symptoms and Risk of Pulmonary Embolism
SI Valentin, Z Viorica, A Denisa, C Sergiu, HL Tony… - ARS Medica … - sciendo.com
ABSTRACT The World Health Organization (WHO) declares COVID 19 pandemic in March
2020. Each pandemic wave had different clinical and biological characteristics, the …
2020. Each pandemic wave had different clinical and biological characteristics, the …
Non-interventional pilot study to monitor the efficacy and safety of lysozyme-based therapy in the treatment of acute sore throat in COVID-19 patients.
M Petrović, S Ritan, G Topić, A Šukalo… - Medical Journal …, 2021 - search.ebscohost.com
English Introduction: Ear, Nose and Throat (ENT) manifestations are frequent symptoms of
COVID-19. Usual empirical doctor's practice in the treatment of sore throat in COVID-19 mild …
COVID-19. Usual empirical doctor's practice in the treatment of sore throat in COVID-19 mild …